Literature DB >> 3897024

Genetic polymorphism of human factor I (C3b inactivator).

S Nakamura, K Abe.   

Abstract

Genetic polymorphism of human factor I (C3b inactivator) has been described using polyacrylamide gel isoelectric focusing electrophoresis of neuraminidase-treated EDTA plasma samples followed by electrophoretic blotting technique. In 435 individuals three different common patterns were observed, and these were controlled by two common alleles at a single locus. The results of typing family material confirmed autosomal codominant Mendelian inheritance. Two common alleles were designated FI*B and FI*A, and gene frequencies were estimated to be 0.8931 and 0.1069 for FI*B and FI*A, respectively. The distribution of phenotypes fitted the Hardy-Weinberg equilibrium. Linkage studies failed to show close linkage between factor I and the major histocompatibility complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897024     DOI: 10.1007/bf00295667

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Linkage of HL-A and GBG.

Authors:  F H Allen
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

2.  Genetic polymorphism of C'3(beta1C-globulin) in human serum.

Authors:  E A Azen; O Smithies
Journal:  Science       Date:  1968-11-22       Impact factor: 47.728

3.  Genetic polymorphism of the seventh component of complement in a Japanese population.

Authors:  S Nakamura; O Ooue; K Abe
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Genetic polymorphism of complement C6 and haplotype analysis between C6 and C7 in a Japanese population.

Authors:  S Nakamura; O Ooue; K Akiyama; K Abe
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Inherited structural variation and linkage relationships of C7.

Authors:  M J Hobart; V Joysey; P J Lachmann
Journal:  J Immunogenet       Date:  1978-06

6.  Genetic polymorphism of human plasminogen.

Authors:  D Raum; D Marcus; C A Alper
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

7.  C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

8.  Genetic polymorphism of human C4-binding protein.

Authors:  S R de Cordoba; A Ferreira; V Nussenzweig; P Rubinstein
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

9.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  A second case of human C3b inhibitor (KAF) deficiency.

Authors:  R A Thompson; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

View more
  5 in total

1.  A new polymorphic variant of human complement factor I.

Authors:  M Zhou; B Larsen
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

2.  Genetic polymorphism of human complement component C81 in the Japanese population.

Authors:  S Nakamura; O Ohue; K Abe
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

3.  Genetic polymorphism of coagulation factor XIII B subunit in the Japanese population: description of three new rare alleles.

Authors:  S Nakamura; O Ohue; K Abe
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

4.  Molecular basis of complement factor I (CFI) polymorphism: one of two polymorphic suballeles responsible for CFI A is Japanese-specific.

Authors:  Isao Yuasa; Mayumi Nakagawa; Kazuo Umetsu; Shinji Harihara; Aya Matsusue; Hiroaki Nishimukai; Yasuo Fukumori; Naruya Saitou; Kyung Sook Park; Feng Jin; Gérard Lucotte; Prasanta K Chattopadhyay; Lotte Henke; Jürgen Henke
Journal:  J Hum Genet       Date:  2008-09-30       Impact factor: 3.172

5.  A new BF F variant by polyacrylamide gel isoelectric focusing.

Authors:  S Nakamura; O Ohue; K Abe
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.